Epithalon, also written Epitalon, is the synthetic tetrapeptide Ala-Glu-Asp-Gly (AEDG). It was developed in Russia as a chemically defined stand-in for epithalamin, a peptide preparation extracted from bovine pineal glands, and it belongs to a group of very short “bioregulator” peptides studied mainly by gerontology laboratories in St. Petersburg.
The research spans pineal physiology, gene expression, oxidative stress and lifespan experiments in invertebrates and rodents, with more recent cell-culture studies that include collaborating laboratories in Italy. Because the field has an unusual history and a concentrated authorship, this overview pays particular attention to what has and has not been independently tested.
At a glance
- Class: Synthetic tetrapeptide; short “peptide bioregulator”
- Origin: Designed by Vladimir Khavinson’s group as a synthetic analog of the pineal extract epithalamin (Araj et al., 2025)
- Structure: Ala-Glu-Asp-Gly; C14H22N4O9; 390.35 g/mol; CAS 307297-39-8
- Main research areas: pineal function, peptide–DNA interaction hypotheses, gene expression in stem-cell cultures, oxidative stress, lifespan models in Drosophila and rodents
- Regulatory status: Not FDA approved for any use
Structure and origin
Epithalamin was one of several crude tissue extracts prepared by Soviet and Russian researchers from the 1980s onward, each named for its source organ. Extracts are hard to standardize, so the same group set out to identify short synthetic peptides that might reproduce their activity. AEDG was proposed as the pineal counterpart and became the most widely studied member of the series (Araj et al., 2025).
Chemically, Epithalon is simple: four common L-amino acids, two of them acidic (glutamate and aspartate), with no modifications at either terminus. At about 390 g/mol it is small and highly polar. That small size underlies the field’s central hypothesis, discussed below, that such peptides might enter cells and the nucleus and interact directly with DNA or chromatin proteins.
Mechanism: what the research shows
No receptor for Epithalon has been identified. Instead, its developers have proposed an epigenetic model in which very short peptides bind specific DNA sequences or histone proteins and thereby alter gene accessibility. Khavinson, Diomede and colleagues tested parts of this idea in human stem-cell cultures, reporting that AEDG increased expression of neurogenesis-associated markers such as nestin and doublecortin at the gene and protein level, and supporting their interpretation with molecular modeling of peptide–histone interactions (Khavinson et al., 2020).
Other proposed mechanisms include effects on antioxidant enzymes and on telomerase activity in cultured cells, both summarized in a 2025 review that also catalogs the pineal and melatonin studies in rats (Araj et al., 2025). These mechanisms have been described mainly by one research network, and direct structural evidence of specific peptide–DNA binding in living cells remains limited.
Confirming the model would require experiments that are largely absent from the current literature: binding measurements with defined DNA or histone targets, demonstration that the intact tetrapeptide reaches the nucleus in meaningful amounts, and genome-wide expression or chromatin-accessibility data from laboratories outside the original network. Until such data exist, the epigenetic model remains a proposal.
Key areas of study
Gene expression and epigenetic hypotheses
Cell-culture studies measure expression of selected genes and proteins after AEDG exposure and pair the results with docking or modeling of possible DNA and histone interactions (Khavinson et al., 2020).
Lifespan studies in Drosophila
An early study exposed fruit flies to Epithalon and reported changes in survival curves compared with controls (Khavinson et al., 2000). Invertebrate lifespan assays are inexpensive and fast but sensitive to diet, temperature and strain, and they do not translate directly to mammals.
Retinal epithelial cell models
Gatta and colleagues used ARPE-19 human retinal pigment epithelial cells cultured in high glucose as an in-vitro model of diabetic retinopathy. In this system, Epithalon was associated with restored scratch-wound closure, lower reactive oxygen species and reduced markers of epithelial–mesenchymal transition (Gatta et al., 2025).
Pineal physiology and rodent studies
Rodent research has examined melatonin secretion and pineal activity in young and old rats, antioxidant enzyme activity, and spontaneous tumor incidence in long-term studies. The 2025 review summarizes these experiments and their designs (Araj et al., 2025).
What the evidence does not show
- The literature is preclinical and comes largely from one network of related laboratories. Independent replication, especially of the lifespan and telomerase findings, is limited.
- Results in flies, rodents and cultured cells do not establish any effect on aging, lifespan, sleep or disease in people.
- The proposed DNA- and histone-binding mechanism rests heavily on modeling and indirect expression data rather than direct structural evidence in cells.
- Older studies often used the extract epithalamin rather than synthetic AEDG; results for one cannot be assumed for the other.
- Epithalon is not an approved drug in the United States.
Regulatory status
Epithalon is not approved by the FDA for any use. Rogue Compounds sells it as a research reagent only, not for human use.
Handling and storage in the lab
Lyophilized Epithalon should be kept sealed and refrigerated at 2–8°C (36–46°F), protected from light.
Sourcing and documentation
Rogue Compounds has Epithalon made in small batches. Every vial carries a batch number and a QR code that opens the independent U.S. testing lab’s own report for that batch, and the same batch COA is on the product page and in the COA Library.
View Epithalon on Rogue Compounds
References
- Khavinson V, et al. Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mech Ageing Dev. 2000;120(1-3):141-149. PMID 11087911
- Khavinson V, et al. AEDG peptide (Epitalon) stimulates gene expression and protein synthesis during neurogenesis: possible epigenetic mechanism. Molecules. 2020;25(3):609. PMID 32019204
- Araj SK, et al. Overview of Epitalon—highly bioactive pineal tetrapeptide with promising properties. Int J Mol Sci. 2025;26(6):2691. PMID 40141333
- Gatta M, et al. The antioxidant tetrapeptide epitalon enhances delayed wound healing in an in vitro model of diabetic retinopathy. Stem Cell Rev Rep. 2025;21(6):1822-1834. PMID 40493162
Research use only. Rogue Compounds products are sold strictly for laboratory research. They are not for human or veterinary use, and nothing in this article is medical advice. The studies cited here describe published research, not this product or any use of it.